Follow us 
07 December, 2024 - CNBCTV18
Dr. Cyrus Poonawalla founder and chairman of Serum institute of India received the Lifetime Achievement Award at CNBC TV18's India Business Leader Awards 2024 (IBLA) for his dedication to humanity and improving public health.
View
31 October, 2024 - TIME
TIME "The Best Inventions of 2024" lists University of Oxford and the Serum Institute of India R21/Matrix-M™ Malaria Vaccine as "A Game-Changing Vaccine"
Read more....
30 October, 2024 - Press Release
Serum Institute of India Pvt. Ltd. receives positive CHMP opinion from European Medicines Agency (EMA) for, a Novel "SIILTIBCY® – Mycobacterium tuberculosis derived antigens (rdESAT-6 and rCFP-10)", intended as a diagnostic aid for detection of Mycobacterium tuberculosis infection.
Read more....
29 August, 2024
Adar Poonawalla, CEO of Serum Institute of India, speaks to Bloomberg TV's Haslinda Amin, Reveals Post-Covid Expansion Plans. View...
31 May, 2024
Serum Institute of India (SII), has been recognized as one of the world's most influential companies by TIME magazine in their 'Most Influential Companies' list for 2024.
Read more....
20 May, 2024 - Press Release
Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses, marks a significant milestone with the shipment of its first set of R21/Matrix-M™ malaria vaccine to Africa.
Read more....
17 May, 2024 - Press Release
Serum Institute of India (SII), the world's largest vaccine manufacturer, has announced a strategic investment in IntegriMedical, acquiring a 20% stake in the company, to advance Needle-Free Injection System technology.
Read more....
03 May, 2024 - Press Release
The collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatment for non-muscle invasive bladder cancer. SII will manufacture both standard BCG (“sBCG”) & next-generation recombinant BCG (“iBCG”), creating a long-term solution to chronic BCG supply shortage issues.
Read more....
25 April, 2024
On World Malaria Day, the architects behind the R21/Matrix-M vaccine present their take on the road ahead.
Read more....
16 April, 2024 - Press Release
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines. This partnership will deliver lifesaving protection against Men-B through the production of a chimeric protein-based vaccine.
Read more....
12 April, 2024 - Press Release
In a landmark collaboration announced today, Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in accessibility to personalised cancer care. This partnership aims to bring cutting edge treatment options within reach of millions globally.
Read more....
02 April, 2024 - Press Release
Bharat Biotech, a global leader in vaccine and biotherapeutic innovation, also the largest manufacturer of oral polio vaccines, and Bilthoven Biologicals B.V., (BBio), a wholly owned subsidiary of Serum Institute of India Private Limited, based in Netherlands, announced a collaboration today, to further strengthen the production and supply security of Oral Polio Vaccines (OPV).
Read more....
01 February, 2024 - Press Release
Phase 3 Trial data results of The R21/Matrix-M™ vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax’s Matrix-M™ adjuvant has confirmed high efficacy and supported regulatory approvals and licensure in several African countries.
Read more....
29 January, 2024
Dr. Cyrus Poonawalla founder and chairman of the Serum Institute of India (SII), was bestowed with a lifetime achievement award by Savitribai Phule Pune University (SPPU).
Read more....
23 January, 2024 - Press Release
The world’s largest vaccine manufacturer, the Serum Institute of India Pvt. Ltd (SII), is joining a growing CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health disease outbreaks.
Read more....
02 October, 2023 - Press Release
The R21/Matrix-M™ malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organization (WHO) after meeting required safety, quality and effectiveness standards. Read more...
20 August, 2023
Serum Institute of India CEO, Adar Poonawalla received the ‘Udyog Mitra’ award from the Government Of Maharashtra. The ‘Maharashtra Industry Awards’ instituted by the Industry Department of Government of Maharashtra from this year were presented by the Hon'ble Governor of Maharashtra Ramesh Bais in Mumbai. Read more...
10 August, 2023
Adar Poonawalla, CEO, Serum Institute of India was awarded the prestigious title of IAA Business Leader of the Year 2023 for unlocking India’s potential in the healthcare sector, for revolutionising vaccine manufacturing, for his outstanding leadership during the covid-19 pandemic, for his commitment to social responsibility and contribution to public health Read more...
August 07, 2023 - Press Release
Cyrus Poonawalla Group, a diversified group of businesses across Pharmaceuticals & Biotechnology, Finance, Clean Energy, Hospitality & Realty and Aviation appoints Mr. Keki Mistry, former HDFC Ltd. CEO & Vice Chairman as the Strategic Advisor to all the Financial Services ventures spearheaded by Mr. Adar Poonawalla. Read more...
06 July, 2023
Hon'ble UK Minister of State; Science, Technology & Innovation, George Freeman and UK Trade Commissioner for South Asia, Harjinder Kang along with members of the UK Trade Commission visit Serum Institute Of India and meet with SII CEO Adar Poonawalla and Chairman Dr. Cyrus Poonawalla. Read more...
04 July, 2023
Watch his insightful and inspiring masterclass session as he takes center stage and shares his experiences and vision in the world of healthcare and vaccine innovation. View...
9 May, 2023
ISPE awards Serum Institute Of India the 2023 Facility of the Year Category Award for Supply Chain and Social Impact. ISPE’s Facility of the Year Awards program is the premier global awards program recognizing innovation and creativity in the pharmaceutical and biotechnology manufacturing industries.
Read more....
13 April, 2023 - Press Release
The University of Oxford-developed and Serum Institute of India Pvt Ltd (SIIPL)- manufactured and scaled up R21/Matrix-M™ malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority. Read more...
1 Mar, 2023
Adar Poonawalla, CEO of Serum Institute of India, joins Forbes India on the next edition of Pathbreakers. View....
02 February, 2023
Seth Berkley CEO of Gavi, the Vaccine Alliance visited the Serum Institute Of India (SII) in Pune and met with SII CEO Adar Poonawalla. Read more....
24 January, 2023
On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, Serum Institute Of India is pleased to launch the first made-in-India qHPV vaccine 'CERVAVAC' by the hands of our Hon'ble Home Minister Shri Amit Shah. Read more....
19 January, 2023
Adar Poonawalla, chief executive of the Serum Institute of India (SII), has spoken about vaccine equity at the World Economic Forum's 2023 Annual Meeting in Davos. Read more....
08 January, 2023
Serum Institute CEO, Adar Poonawalla was conferred with the first Dr. Patangrao Kadam Memorial Award at the inauguration of the Bharti Super Specialty Hospital at Bharti Vidyapeeth, Pune on Sunday 8th January 2023. Read more....
15 December, 2022
More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by the Serum Institute of India in just 60 days and doses shipped to Uganda. Read more....
17 September, 2022
In regulation, R&D and engagement with private sector, India must internalise lessons learnt, writes Adar Poonawalla, CEO of Serum Institute of India. Read more....
01 September, 2022
Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology & Earth Sciences announced India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine 'CERVAVAC' for the prevention of cervical cancer. Read more....
24 August, 2022
Serum Institute of India CEO Adar Poonawalla called on Hon'ble Prime Minister Shri. Narendra Modi and congratulated him for his leadership in the fight against the COVID-19 pandemic. Read more....
17 August, 2022
Highlighting 75 years of U.S.-India bilateral relationship and their cooperation on health issues, a delegation from the United States visited the Serum Institute of India. Read more....
23 May, 2022
Dr. Poonawalla has been felicitated with Dean’s medal for his lifelong contribution with this honor.... Read more....
7 May, 2022
Adar Poonawalla, CEO of Serum Institute of India receives the Business Leader of The Year award at The Economic Times Awards for Corporate Excellence... Read more....
3 May, 2022
Children aged 12 to 17 years in India can now get the Serum Institute of India's (SII) Covid-19 vaccine Covovax... Read more....
12 April, 2022
Adar Poonawalla, CEO, Serum Institute of India, receives the Business Leader of the Year award from All India Management Association... Read more....
1 April, 2022
Adar Poonawalla, CEO, Serum Institute of India, was conferred the award for Outstanding Business Leader of the Year at CNBC-TV18's India Business Leaders Awards (IBLA) 2022... Read more....
21 March, 2022
Hon'ble President of India, Shri Ram Nath Kovind confers the Padma Bhushan Award to Dr. Cyrus Poonawalla, Chairman and Managing Director of Serum Institute of India at a civil investiture ceremony held at Rashtrapati Bhavan... Read more....
10 March, 2022
NEW DELHI: In a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year olds. This is the fourth vaccine to get regulatory approval for use in youngsters... Read more....
15 February, 2022
Serum Insitute of India chairman Cyrus Poonawalla on Monday said that poor nations of the world are using the vaccines made by the company as the doses have been made available at a price of a "cup of tea"... Read more....
3 February, 2022
The CEO of Serum Institute of India is finding newer frontiers to invest the family wealth. And he ensures these companies have the potential to complement the world's largest vaccine maker... Read more....
26 January, 2022
One of the highest civilian awards in the country, the Padma Bhushan has been awarded to Dr Poonawalla for exceptional and distinguished service in trade and industry field... Read more....
25 January, 2022
Dr. Cyrus Poonawalla, Chairman and Managing Director of Serum Institute of India to be conferred with the Padma Bhushan Award... Read more....
8 January, 2022 - India Today
Adar Poonawalla, CEO of Serum Institute of India, speaks to India Today Group Editorial Director Raj Chengappa on the Covid vaccine journey and his plans ahead... View...
17 December, 2021
World Health Organization (WHO) has granted Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine 'COVOVAX™' with Matrix-M™ adjuvant, for active immunization of individuals 18 years of age and older for the prevention of coronavirus disease 2019 caused by SARS-CoV-2... Read more...
15 December, 2021
The Poonawalla Vaccines Research Building is to be established at Oxford University following £50m funding commitment from Serum Life Sciences Ltd., a subsidiary of Serum Institute of India Pvt. Ltd. Read more...
26 November, 2021 - Press Release
Serum Institute of India (SII) today announces it has resumed exports to the international vaccine sharing programme COVAX... Read more...
17 November, 2021
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Novavax' recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant. The vaccine will be manufactured and marketed in the Philippines by SII under the brand name COVOVAX™... Read more...
1 November, 2021
The National Agency of Drug and Food Control of the Republic of Indonesia, or Badan Peng was Obat dan Makanan (Badan POM), has granted emergency use authorization (EUA) for Novavax' recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant. It will be manufactured by SII in India and marketed by SII in Indonesia under the brand name COVOVAX™... Read more...
22 September, 2021
Serum Life Sciences Ltd announces a strategic partnership with Oxford Biomedica, with the objective of building long term capacity in the UK. Read more...
16 September, 2021
Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd. today announced a strategic alliance... Read more...
15 September, 2021
From the beginning of the pandemic, Adar Poonawalla sought to meet the moment...Read more...
17 August, 2021
Serum Institute of India (SII) acquires 50% stake of SCHOTT Kaisha to become SCHOTT’s joint venture partner and secure pharma packaging supply...Read more...
13 August, 2021
Dr. Cyrus Poonawalla received the prestigious Lokmanya Tilak National Award 2021...Read more...
26 June, 2021
Sayfty Trust & Villoo Poonawalla Foundation co-hosted a two-day virtual summit for women and other...View...
08 February, 2021
UK delegation led by Secretary of State for International Trade, Liz Truss visited the Serum Institute of India...Read more...
03 February, 2021
Today, we are pleased to announce the conclusion of a long-term supply agreement with the Serum Institute of India for the COVID-19 vaccines, to access two vaccine products through technology transfer from AstraZeneca and Novavax...Read more...
Source: The Economic Times
29 January, 2021
US biotech firm Novavax has said that its Covid-19 vaccine was 89.3% effective in preventing the killer virus in a trial conducted in the United Kingdom...Read more...
Source: LiveMint
23 January, 2021
Battling the second wave of Covid-19, South Africa is expected to receive a million doses of Covishield by the end of January and another 5 lakh in February of this year...Read more...
Source: India Today
18 January, 2021
AstraZeneca is engaging with governments, multilateral organisations and other partners around the world for broad and equitable access...Read more...
Source: LiveMint
16 January, 2021
A sense of joy and excitement was witnessed at vaccination centres across states as Corona Warriors queued up for their first jab...Read more...
Source: IndiaToday
16 January, 2021
I wish India & Sri Narendra Modi Ji great success in launching the world’s largest COVID vaccination roll-out...Read more...
11 January, 2021
Pune-based Serum Institute of India also confirmed that it has received a purchase order from the Government of India for 1.1 crore doses of its coronavirus vaccine 'Covishield'...Read more...
Source: The Economic Times
04 January, 2021
Drug Controller General of India VG Somani said,."We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe"...Read more...
Source: The Economic Times
03 January, 2021
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine...Read more...
Source: The Economic Times
30 December, 2020
Serum Institute Of India Chairman & Managing Director, Dr. Cyrus Poonawalla talks to TV 18 regrading the Covid-19: Oxford-AstraZeneca vaccine approved for use in UK...View...
29 December, 2020
Serum Institute of India (SII) CEO Adar Poonawalla said on December 28, that the vaccine is likely to get an emergency-use licence from the UK Medicines...Read more...
Source: Business Today
29 December, 2020
Union Health Minister Dr. Harsh Vardhan launched India’s first indigenously developed pneumococcal vaccine, 'PNEUMOSIL' manufactured by the Serum Institute of India...View...
28 December, 2020
The vaccine called PNEUMOSIL® will primarily help to fight against pneumococcal pneumonia amongst children and will be available...Read more...
26 December, 2020
Pune-based SII is to submit an updated safety data of phase 2 and 3 clinical trials in India, immunogenicity data from the clinical trial in the UK and India...Read more...
Source: Business Today
24 December, 2020
According to the sources, the vaccine will be much more affordable than existing ones manufactured by two foreign companies...Read more...
Source: LiveMint
17 December, 2020
The world's largest vaccine maker, Serum Institute of India (SII), could soon become the world’s first company to produce a 'Green Vaccine'...Read more...
Source: MSN News
15 December, 2020
Serum Institute of India has already manufactured 40 million doses of the Oxford-AstraZeneca COVID-19 vaccine...Read more...
Source: MoneyControl
11 December, 2020
So far, SII has made 5 crore doses of the Oxford University-AstraZeneca vaccine...Read more...
Source: LiveMint
11 December, 2020
The Serum Institute has taken on a vital role as the largest company licensed to manufacture the Oxford University-AstraZeneca coronavirus vaccine...Read more...
Source: CNBC-TV 18
05 December, 2020
SII has collaborated with Oxford University and AstraZeneca for making the COVID-19 vaccine...Read more...
Source: The Economic Times
28 November, 2020
The Prime Minister interacted with top scientists at Serum Institute of India and sought to know the status of the trials...Read more...
Source: Indian Express
20 November, 2020
Vaccine maker Serum Institute of India's CEO Adar Poonawalla on thursday said the Oxford Covid-19 vaccine shoud be available...Read more...
Source: Times of India
19 November, 2020
The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion of the Covid-19 pandemic...View...
11 November, 2020
The strategic alliance between the SII and the ICMR will advance India’s role in the global race to develop COVID-19 vaccines...Read more...
05 November, 2020
Adar Poonawalla, CEO of SII said preliminary results have shown that there are no immediate concerns pertaining to the Covishield vaccine...Read more...
Source: The Indian Express
03 November, 2020
In a major development, India and Brazil have secured the rights to buy enough quantities of COVID-19 vaccine...Read more...
Source: Swarajya
28 October, 2020
Adar Poonawalla, CEO of Serum Institute of India in an exclusive interview with NDTV's Vishnu Som...View...
22 October, 2020
Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response...Read more...
12 October, 2020
The trial involves 1,600 volunteers in 17 cities across the country...Read more...
Source: The Hindu
07 October, 2020
When the coronavirus pandemic broke out earlier this year, Adar Poonawalla, CEO of Serum Institute of India, the world’s largest vaccine maker by number of doses produced and sold, weighed the options...Read more...
Source: Forbes
29 September, 2020
The announcement takesforward the collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation...Read more...
23 September, 2020
Vaccine Update from the World’s Largest Vaccine Manufacturer Adar Poonawalla the CEO of Serum Institute of India joins Julia Chatterley to discuss the latest developments in their COVID-19 vaccine...View...
22 September, 2020
Serum Institute has received necessary regulatory approval from the Review Committee on Genetic Manipulation (RCGM) of India's Department of Biotechnology (DBT) for manufacturing Codagenix's COVID-19 vaccine candidate...Read more...
Source: MoneyControl
19 September, 2020
The phase III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week, said Dr Muralidhar Tambe, Dean of Sassoon General Hospital...Read more...
Source: liveMint
18 September, 2020
US drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually...Read more...
Source: liveMint
16 September, 2020
Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID – 19 - Co Hosted by the Johns Hopkins India Institute...View...
15 September, 2020
As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate...Read more...
Source: liveMint
13 September, 2020
The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants...Read more...
Source: India Today
08 September, 2020
The Oxford University-AstraZeneca covid vaccine is now undergoing Phase III clinical trials in Britain, Brazil, South Africa and India...Read more...
Source: liveMint
29 August, 2020
The deal announced by the Bangladeshi generic drugmaker comes after Dhaka said this month it was ready to hold trials of candidate vaccines being developed by India as both countries seek to curb the spread of the virus...Read more...
Source: liveMint
The Johns Hopkins University, Baltimore, USA has awaeded its highest honour to Dr. Cyrus Poonawalla...Read more...
26 August, 2020
The 'Covishield' vaccine's trials begin with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune...Read more...
Source: livemint
20 August, 2020
Country’s apex biomedical research agency is also helping Zydus Cadila for laboratory assays to detect antibody response, according to documents reviewed by Mint...Read more...
Source: livemint
19 August, 2020
A total of 1,600 candidates will take part in the study. King Edward Memorial Hospital Parel, and BYL Nair Hospitals, Mumbai Central — have received approval from ICMR to start the trial...Read more...
Source: livemint
18 August, 2020
Serum Institute of India (SII) will begin the phase 2 clinical trials of a promising coronavirus vaccine developed by the University of Oxford this week...Read more...
Source: Times Now News
18 August, 2020
The company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccine candidates, ET has learnt...Read more...
Source: The Economic Times
11 August, 2020
The Serum Institute of India is preparing to crank out a billion doses. And that's just the beginning...Read more...
Source: Bloomberg
10 August, 2020
SII is part of the agreement with AstraZeneca, which along with Oxford University has developed a vaccine that has reported satisfactory progress from the test results...Read more...
Source: News18
07 August, 2020
New landmark collaboration between the Serum Institute of India (SII), Gavi, and Bill & Melinda Gates Foundation...Read more...
06 August, 2020
On Tuesday, Novavax reported that its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus in a small...Read more...
Source: The Indian Express
01 August, 2020
Earlier this week, a committee of experts had deferred a decision on the request of SII to start trials and asked the company to amend its protocol for the clinical study...Read more...
Source: The Economic Times
27 July, 2020
About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine...Read more...
Source: MoneyControl
22 July, 2020
Adar Poonawalla said if the vaccine trials go fine and the results are favourable, Serum Institute of India will be manufacturing this Covid-19 vaccine as a partner with Oxford University... Read more...
Source: IndiaToday
21 July, 2020
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca... Read more...
Source: News18
18 July, 2020
Serum Institute CEO Adar Poonawalla speaks to The Indian Express about their efforts to develop Covid-19 vaccines... Read more...
Source: The Indian Express
15 July, 2020
New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune... Read more...
Source: LiveMint
8 July, 2020
He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate lab processes from sample handling to preparing RT-PCR tubes... Read more...
Source: ExpressPharma
17 June, 2020
Pneumonia is the biggest single killer of children, claiming the life of a child every 39 seconds...Read more...
Source: LiveMint
10 June, 2020
Our manufacturing facility is ready and we plan to start production in two months. We are spending more than USD 100 million for this facility...Read more...
Source: ET HealthWorld
05 June, 2020
The Pune-based company has executed the deal through its German subsidiary mPower GmbH...Read more...
Source: MoneyControl
04 June, 2020
World leaders make historic commitments to provide equal access to vaccines for all... Read more...
Source: Gavi
05 June, 2020
The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine... Read more...
Source: University of Oxford
04 June, 2020
The British drug maker also reached a $750m agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and Gavi to support the manufacturing, procurement... Read more...
Source: The Economic Times
04 June, 2020
Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic...Read more...
Source: Forbes India
28 May, 2020
Serum Institute has currently joined hands with various global pharmaceutical institutes and firms in efforts to produce a vaccine for Covid-19... Read more...
Source: Hindustan Times
28 April, 2020
In this episode of To The Point, RSTV Speaks to Adar Poonawalla, CEO and Owner, Serum Institute of India. As the world races to find a cure for the deadly novel coronavirus,... View...
06 April, 2020
With Indian authorities expediting approvals, a viable Coronavirus vaccine may be commercially available earlier than anticipated... Read more...
Source: Fotune India
02 April, 2020
As governments race to get a handle on the spread of the coronavirus and cure the affected people, the medical community has been busy working...Read more...
Source: CNBC TV18
02 April, 2020
Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd has partnered with Serum Institute of India’s CEO Adar Poonawalla and Abhijit Pawar,...Read more...
Source: HealthWorld | Economic Times
01 April, 2020
Serum Institute of India has partnered with American biotechnology firm @Codagenix to develop a vaccine against COVID-19, and expects it to be ready by early 2022... Read more...
12 March, 2020
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company... View...
Source: TIMES NOW NEWS
10 March, 2020
Cyrus Poonawalla's Serum Institute has signed a joint venture with US company Codagenix to work on a coronavirus cure... Read more...
Source: The Telegraph
07 March, 2020
Serum Institute of India, world’s largest vaccine producer by number of doses produced, headquartered in Pune, has stated that the vaccine for COVID-19 will not be readied before 2022... Read more...
Source: NEWS18 India
19 December, 2019
This milestone marks a key step toward improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low- and middle-income countries... Read more...
Source: Path
16 December, 2019
Serum Institute of India and Villoo Poonawalla Foundation have collaborated with the Camp Education Society to upgrade the infrastructure of two schools... Read more...
Source: India Today
17 November, 2019
Dr. Cyrus Poonawalla was conferred with the Indian Council of Medical Research (ICMR) 'Lifetime Achievement Medal' for his outstanding contribution... Read more...
06 November, 2019
Dr. Cyrus Poonawalla was conferred with the 'Lifetime Achievement Award’ by the Asian Business Leadership Forum (ABLF) at the awards ceremony held on 6th November 2019 in Dubai... Read more...
Source: Sakal Newspaper
09 September, 2019
Serum Institute of India's new plant inaugurated by Hon'ble Union Health Minister Dr. Harsh Vardhan... Read more...
26 June, 2019
Dr. Cyrus Poonawalla was conferred with the prestigious 'Degree of Doctor of Science, honoris causa' by the University of Oxford, U.K. at a glittering ceremony... Read more...
10 December, 2018
Dr. Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi... Read more...
7 April, 2018
Mr Adar Poonawalla, CEO, Serum Institute of India, receiving the prestigious... Read more...
November, 2017
Adar Poonawalla, CEO of Serum Institute received the Outsatanding achievement in Business & CSR from CNN-News18's Indian of the Year... Read more...
8 September, 2017
Prime Minister Narendra Modi’s recent nomination of Pune industrialist Adar Poonawalla, as ambassador for the Swachh Bharat mission, comes in recognition of his major initiative towards a cleaner and greener Pune... Read more...
15 November, 2016
Adar Poonawalla's clean city initiative launched in collaboration with the Pune Municipal Corporation this January has struck a chord with Prime Minister Narendra Modi... Read more...
13 November, 2016
Hon'ble Prime Minister Shri. Narendra Modi visited the Serum Institute of India on Sunday 13th November and met with the Chairman & Managing Director Dr. Cyrus Poonawalla and CEO Mr. Adar Poonawalla... Read more...
